These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 17120688)

  • 1. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
    Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
    Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
    Mouzas IA; Papavassiliou E; Koutroubakis I
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease and its association with colorectal cancer.
    Schechter S
    R I Med; 1995 Jun; 78(6):161-3. PubMed ID: 7626814
    [No Abstract]   [Full Text] [Related]  

  • 17. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Vleggaar FP; Lutgens MW; Claessen MM
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
    Vetter C
    MMW Fortschr Med; 2005 Mar; 147(13):10. PubMed ID: 15832752
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
    Giannini EG; Kane SV; Testa R; Savarino V
    Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.